Clinical significance of ASCUS and ASC-H cytological abnormalities: a six-year experience at a single center
dc.contributor.author | Demirtas, G. S. | |
dc.contributor.author | Akman, L. | |
dc.contributor.author | Demirtas, O. | |
dc.contributor.author | Hursitoglu, B. S. | |
dc.contributor.author | Terek, M. C. | |
dc.contributor.author | Zekioglu, O. | |
dc.contributor.author | Yilmaz, H. | |
dc.contributor.author | Ozsaran, A. A. | |
dc.date.accessioned | 2019-10-27T22:29:50Z | |
dc.date.available | 2019-10-27T22:29:50Z | |
dc.date.issued | 2015 | |
dc.department | Ege Üniversitesi | en_US |
dc.description.abstract | Background: To evaluate colposcopic biopsy results of patients with cervical cytological findings of atypical squamous cells of undetermined significance (ASC-US) and atypical squamous cells with high-grade lesions that cannot be excluded (ASC-H). Materials and Methods: A retrospective evaluation of data from 358 patients, who had cervical cytological findings of ASC-US (n=335) and ASC-H (n=23), and had colposcopic assessments between 2005 and 2011. Results: Cervical biopsy results of patients diagnosed with ASC-US cytology (n=335) revealed cervical squamous cell carcinoma 0.9 % (n=3) at biopsy, cervical intraepithelial neoplasia 3 (ON 3) in 3.8 % (n=13), cervical intraepithelial neoplasia 2 (CIN 2) in 1.1 % (n=4), cervical intraepithelial neoplasia 1 (CIN 1) in 35.2 % (n=118), and benign lesions in 59% (n=197). Cervical biopsy results of patients diagnosed with ASC-H cytology (n=23) revealed CIN 3 at biopsy in 39.3% (n=9), CIN 2 in 21.7% (n=5), CIN 1 in 26% (n=6), carcinoma in situ in 8.7% (n=2), and squamous cell cancer in one patient (4.3%). Conclusion: The cytological diagnosis of ASC-US may lead to the diagnosis of cervical intraepithelial lesion of higher grades as well as cervical cancer and should be evaluated by colposcopic cervical biopsy. | en_US |
dc.identifier.endpage | 154 | en_US |
dc.identifier.issn | 0392-2936 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 26050352 | en_US |
dc.identifier.scopusquality | N/A | en_US |
dc.identifier.startpage | 150 | en_US |
dc.identifier.uri | https://hdl.handle.net/11454/51166 | |
dc.identifier.volume | 36 | en_US |
dc.identifier.wos | WOS:000354003200010 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | 7847050 Canada Inc | en_US |
dc.relation.ispartof | European Journal of Gynaecological Oncology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | ASCUS | en_US |
dc.subject | ASC-H | en_US |
dc.subject | Cervical cytology | en_US |
dc.subject | Colposcopy | en_US |
dc.title | Clinical significance of ASCUS and ASC-H cytological abnormalities: a six-year experience at a single center | en_US |
dc.type | Article | en_US |